The Journal of infection

• Latest
• Best
• Search…

• The Journal of infection · Jul 2020

  Comment Letter

  Clinical features of critically ill patients with confirmed COVID-19.

  no abstract available

  read more… or not…

• The Journal of infection · Jul 2020

  Comment Letter

  Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.

  no abstract available

  expand abstract… or not…

• The Journal of infection · Jul 2020

  Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study.

  Corona Virus Disease 2019 (COVID-19) due to the 2019 novel coronavirus (SARS-CoV-2) emerged in Wuhan city and rapidly spread throughout China. We aimed to compare arbidol and lopinavir/ritonavir(LPV/r) treatment for patients with COVID-19 with LPV/r only. ⋯ In patients with COVID-19, the apparent favorable clinical response with arbidol and LPV/r supports further LPV/r only.

  explore further… or just mark as read…

• The Journal of infection · Jul 2020

  Letter

  Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources.

  no abstract available

  expand abstract… or not…

• The Journal of infection · Jun 2020

  Comment Letter

  Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.

  no abstract available

  keep reading… or just mark as read…